Envista Holdings (NVST) Cash from Investing Activities (2018 - 2026)
Envista Holdings (NVST) recorded quarterly Cash from Investing Activities of -$68.9 million in Q2 2026, down 344.52% quarter-over-quarter from -$15.5 million in Q4 2025, and down 682.95% on a YoY basis from $11.8 million in Q2 2025.
Envista Holdings (NVST) Cash from Investing Activities (2018 - 2026) Analysis & Trends
Envista Holdings' Cash from Investing Activities history runs 9 years deep, the most recent figure standing at -$68.9 million for Q2 2026.
- In Q2 2026, Cash from Investing Activities fell 682.95% year-over-year to -$68.9 million; the TTM figure through Apr 2026 stood at -$111.2 million (down 111.01% YoY), while the FY2025 annual figure was -$51.1 million, up 6.41% from the prior year.
- Cash from Investing Activities was -$68.9 million for Q2 2026 at Envista Holdings, down from -$15.5 million in the prior quarter.
- In the past five years, Cash from Investing Activities ranged from a high of $5.1 million in Q2 2022 to a low of -$591.6 million in Q3 2022.
- Historically, Cash from Investing Activities has averaged -$52.6 million across 5 years, with a median of -$12.6 million in 2023.
- Biggest YoY gain for Cash from Investing Activities was 192.73% in 2022; the steepest drop was 3319.65% in 2022.
- A 5-year view of Cash from Investing Activities shows it stood at -$1.1 million in 2022, then plunged by 1045.45% to -$12.6 million in 2023, then jumped by 41.27% to -$7.4 million in 2024, then sank by 109.46% to -$15.5 million in 2025, then plunged by 344.52% to -$68.9 million in 2026.
- The last three Cash from Investing Activities figures came in at -$68.9 million (Q2 2026), -$15.5 million (Q4 2025), and -$9.7 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 148.09 Bn | 143.69 Bn | 1.83 Bn | -914.50 Mn |
| 2 | Becton Dickinson | 41.00 Bn | 39.99 Bn | 2.15 Bn | -139.00 Mn |
| 3 | Medline | 30.38 Bn | 36.22 Bn | 1.84 Bn | -96.00 Mn |
| 4 | Resmed | 28.22 Bn | 26.56 Bn | 890.98 Mn | -58.03 Mn |
| 5 | West Pharmaceutical Services | 23.72 Bn | 23.19 Bn | 296.40 Mn | -42.70 Mn |
| 6 | Solventum | 13.33 Bn | 13.33 Bn | 1.10 Bn | -77.00 Mn |
| 7 | Cooper Companies | 13.12 Bn | 12.99 Bn | 735.40 Mn | -90.00 Mn |
| 8 | Align Technology | 12.86 Bn | 11.80 Bn | 736.59 Mn | -131.58 Mn |
| 9 | Baxter International | 10.51 Bn | 8.47 Bn | 891.00 Mn | -133.00 Mn |
| 10 | Envista Holdings | 4.06 Bn | 2.98 Bn | 390.10 Mn | -68.90 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 3, 2026 | -68.90 Mn |
| Apr 3, 2026 | -68.90 Mn |
| Dec 31, 2025 | -15.50 Mn |
| Dec 31, 2025 | -15.50 Mn |
| Sep 26, 2025 | -9.70 Mn |
| Sep 26, 2025 | -9.70 Mn |
| Jun 27, 2025 | -17.10 Mn |
| Jun 27, 2025 | -17.10 Mn |
| Mar 28, 2025 | -8.80 Mn |
| Mar 28, 2025 | -8.80 Mn |
| Dec 31, 2024 | -7.40 Mn |
| Dec 31, 2024 | -7.40 Mn |
| Sep 27, 2024 | -30.60 Mn |
| Sep 27, 2024 | -30.60 Mn |
| Jun 28, 2024 | -5.90 Mn |
| Jun 28, 2024 | -5.90 Mn |
| Mar 29, 2024 | -10.70 Mn |
| Mar 29, 2024 | -10.70 Mn |
| Dec 31, 2023 | -12.60 Mn |
| Dec 31, 2023 | -12.60 Mn |